Literature DB >> 15273405

DNaseI hypersensitivity analysis of chromatin structure.

Qianjin Lu1, Bruce Richardson.   

Abstract

Transcriptionally inactive DNA is packaged into condensed chromatin such that it is unavailable to the transcription initiation complex. Activation of the silenced genes during processes such as differentiation first requires that the chromatin structure be remodeled into a transcriptionally permissive configuration, with the DNA "exposed" and accessible to transcription factors. The change in chromatin structure associated with transcriptional competence can be detected as increased sensitivity of the exposed DNA to digestion with DNaseI. This increased susceptibility is referred to as DnaseI-hypersensitivity. DNaseI hypersensitive sites are often located in the recognition sites for transcription factors, including promoters and enhancers. This chapter describes the protocols necessary to perform and analyze DNaseI hypersensitivity assays, a technique becoming increasingly important given the rapid advances in our understanding of the chromatin remodeling processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273405     DOI: 10.1385/1-59259-828-5:077

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  DNase I digestion of isolated nulcei for genome-wide mapping of DNase hypersensitivity sites in chromatin.

Authors:  Guoyu Ling; David J Waxman
Journal:  Methods Mol Biol       Date:  2013

2.  PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA.

Authors:  Hyesuk Yoon; Jeremy M Boss
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

3.  Complexities of Understanding Function from CKD-Associated DNA Variants.

Authors:  Jennie Lin; Katalin Susztak
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-08       Impact factor: 8.237

4.  Dynamics and memory of heterochromatin in living cells.

Authors:  Nathaniel A Hathaway; Oliver Bell; Courtney Hodges; Erik L Miller; Dana S Neel; Gerald R Crabtree
Journal:  Cell       Date:  2012-06-14       Impact factor: 41.582

5.  Transcription factor BORIS (Brother of the Regulator of Imprinted Sites) directly induces expression of a cancer-testis antigen, TSP50, through regulated binding of BORIS to the promoter.

Authors:  Natsuki Kosaka-Suzuki; Teruhiko Suzuki; Elena M Pugacheva; Alexander A Vostrov; Herbert C Morse; Dmitri Loukinov; Victor Lobanenkov
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

6.  Combining ATAC-seq with nuclei sorting for discovery of cis-regulatory regions in plant genomes.

Authors:  Zefu Lu; Brigitte T Hofmeister; Christopher Vollmers; Rebecca M DuBois; Robert J Schmitz
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

7.  ABCC6 expression is regulated by CCAAT/enhancer-binding protein activating a primate-specific sequence located in the first intron of the gene.

Authors:  Marcin Ratajewski; Hugues de Boussac; Iwona Sachrajda; Caroline Bacquet; Tünde Kovács; András Váradi; Lukasz Pulaski; Tamás Arányi
Journal:  J Invest Dermatol       Date:  2012-07-05       Impact factor: 8.551

8.  The forkhead factor FoxE1 binds to the thyroperoxidase promoter during thyroid cell differentiation and modifies compacted chromatin structure.

Authors:  Isabel Cuesta; Kenneth S Zaret; Pilar Santisteban
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

Review 9.  Unravelling the complex genetics of common kidney diseases: from variants to mechanisms.

Authors:  Katie Marie Sullivan; Katalin Susztak
Journal:  Nat Rev Nephrol       Date:  2020-06-08       Impact factor: 28.314

10.  Transcriptional regulation of the ABCC6 gene and the background of impaired function of missense disease-causing mutations.

Authors:  Tamás Arányi; Caroline Bacquet; Hugues de Boussac; Marcin Ratajewski; Viola Pomozi; Krisztina Fülöp; Christopher N Brampton; Lukasz Pulaski; Olivier Le Saux; András Váradi
Journal:  Front Genet       Date:  2013-03-11       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.